input_term,match_1,score_1,match_2,score_2,match_3,score_3,match_4,score_4,match_5,score_5
25-30% DUCTAL COMPONENT,Prostate Ductal Adenocarcinoma,0.3333333333333333,"Prostate Ductal Adenocarcinoma, Papillary Pattern",0.2727272727272727,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",0.2727272727272727,"Prostate Ductal Adenocarcinoma, Solid Pattern",0.2727272727272727,Prostate Adenocarcinoma,0.2222222222222222
AB,"Penile Squamous Cell Carcinoma, Usual Type",0.3,Adrenal Cortical Carcinoma,0.25,Childhood Adrenal Cortical Carcinoma,0.2222222222222222,Recurrent Adrenal Cortical Carcinoma,0.2222222222222222,Refractory Adrenal Cortical Carcinoma,0.2222222222222222
ACANTHOLYTIC,Skin Acantholytic Squamous Cell Carcinoma,0.7555555555555555,Laryngeal Acantholytic Squamous Cell Carcinoma,0.6000000000000001,"Breast Squamous Cell Carcinoma, Acantholytic Variant",0.5636363636363637,Skin Squamous Cell Carcinoma,0.4444444444444444,Recurrent Skin Squamous Cell Carcinoma,0.4
ACC,"Penile Squamous Cell Carcinoma, Usual Type",0.3,Adrenal Cortical Carcinoma,0.25,Childhood Adrenal Cortical Carcinoma,0.2222222222222222,Recurrent Adrenal Cortical Carcinoma,0.2222222222222222,Refractory Adrenal Cortical Carcinoma,0.2222222222222222
ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA RELATED CHANGES,Acute Myeloid Leukemia with BCR-ABL1,0.5636363636363637,Acute Myeloid Leukemia with Maturation,0.5636363636363637,Acute Myeloid Leukemia with FUS-ERG,0.5636363636363637,Acute Myeloid Leukemia with NPM1-MLF1,0.5636363636363637,Acute Myeloid Leukemia with KAT6A-CREBBP,0.5636363636363637
ACYC,Salivary Gland Adenoid Cystic Carcinoma,0.9142857142857144,Minor Salivary Gland Adenoid Cystic Carcinoma,0.825,Major Salivary Gland Adenoid Cystic Carcinoma,0.825,Bartholin Gland Adenoid Cystic Carcinoma,0.7,Parotid Gland Adenoid Cystic Carcinoma,0.7
ADENOCARINOMA,Fallopian Tube Cancer by AJCC v8 Stage,0.3,Stage I Fallopian Tube Cancer AJCC v8,0.3,Stage IA Fallopian Tube Cancer AJCC v8,0.3,Stage IB Fallopian Tube Cancer AJCC v8,0.3,Stage IC Fallopian Tube Cancer AJCC v8,0.3
AMELANOTIC NODULAR,Amelanotic Cutaneous Melanoma,0.8,Amelanotic Melanoma,0.6000000000000001,Cutaneous Nodular Melanoma,0.6,Cutaneous Melanoma,0.4,Nodular Melanoma,0.4
AML WITH BIALLELIC MUTATIONS OF CEBPA,Acute Myeloid Leukemia with Biallelic CEBPA Mutation,0.36363636363636365,Acute Myeloid Leukemia with CEBPA Mutation,0.2727272727272727,Acute Myeloid Leukemia with Germline CEBPA Mutation,0.25,Acute Myeloid Leukemia with Monoallelic CEBPA Mutation,0.25,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.25
AML WITH MUTATED CEBPA,Acute Myeloid Leukemia with Biallelic CEBPA Mutation,0.3333333333333333,Acute Myeloid Leukemia with Mutated TP53,0.25,Acute Myeloid Leukemia with CEBPA Mutation,0.25,Acute Myeloid Leukemia with Germline CEBPA Mutation,0.23076923076923078,Acute Myeloid Leukemia with Monoallelic CEBPA Mutation,0.23076923076923078
AML WITH MUTATED NPM1,Acute Myeloid Leukemia with Mutated TP53,0.3333333333333333,Acute Myeloid Leukemia with NPM1 Mutation,0.3333333333333333,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Mutated TP53,0.2727272727272727,B Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R),0.25,Acute Myeloid Leukemia with BCR-ABL1,0.2222222222222222
AML WITH MUTATED RUNX1,Acute Myeloid Leukemia with Mutated TP53,0.3333333333333333,Acute Myeloid Leukemia with RUNX1 Mutation,0.3333333333333333,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Mutated TP53,0.2727272727272727,B Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R),0.25,Acute Myeloid Leukemia with BCR-ABL1,0.2222222222222222
AML WITH MYELODYSPLASIA-RELATED CHANGES,Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.3,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.3,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.25,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.25,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.25
"AML, NOS",Leukemia,0.25,Testicular Leukemia,0.2,"Supratentorial Ependymoma, YAP1-MAMLD1 Fusion-Positive",0.2,Meningeal Leukemia,0.2,Leukemia Cutis,0.2
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,"Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",0.34285714285714286,"Cutaneous Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",0.33333333333333337,"Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",0.33333333333333337,"Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",0.33333333333333337,"Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type by Ann Arbor Stage",0.3111111111111111
ANSC,Primary Myelofibrosis,0.3333333333333333,Refractory Primary Myelofibrosis,0.2857142857142857,Recurrent Primary Myelofibrosis,0.2857142857142857,Overt Primary Myelofibrosis,0.2857142857142857,Accelerated Phase Primary Myelofibrosis,0.25
APAD,Adenocarcinoma,0.25,Vaginal Adenocarcinoma,0.2,Mesonephric Adenocarcinoma,0.2,Vulvar Adenocarcinoma,0.2,Ovarian Adenocarcinoma,0.2
APL WITH PML-RARA,Adenocarcinoma with Metaplasia,0.34285714285714286,Adenocarcinoma with Squamous Metaplasia,0.325,Adenocarcinoma with Apocrine Metaplasia,0.325,Adenocarcinoma with Osseous Metaplasia,0.325,Adenocarcinoma with Cartilaginous Metaplasia,0.325
ASPS,Lung Alveolar Soft Part Sarcoma,0.7142857142857143,Alveolar Soft Part Sarcoma,0.5714285714285714,Cervical Alveolar Soft Part Sarcoma,0.5,Vulvar Alveolar Soft Part Sarcoma,0.5,Bladder Alveolar Soft Part Sarcoma,0.5
ASTROCYTOMA_GRADE_III-IV,Cervical Squamous Cell Carcinoma,0.4,Metastatic Cervical Squamous Cell Carcinoma,0.36363636363636365,Advanced Cervical Squamous Cell Carcinoma,0.36363636363636365,Refractory Cervical Squamous Cell Carcinoma,0.36363636363636365,Unresectable Cervical Squamous Cell Carcinoma,0.36363636363636365
ATL,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,0.18181818181818182,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.16666666666666666,Stage I Bladder Cancer with Carcinoma In Situ,0.15384615384615385,Stage I Bladder Cancer without Carcinoma In Situ,0.15384615384615385,Transformed EGFR-Positive Lung Adenocarcinoma to Squamous Cell Carcinoma,0.15384615384615385
"ATYPICAL CHRONIC MYELOID LEUKAEMIA, BCR-ABL1 NEGATIVE",Atypical Chronic Myeloid Leukemia,0.5333333333333333,Recurrent Atypical Chronic Myeloid Leukemia,0.5076923076923077,"Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive",0.3333333333333333,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.3076923076923077,"Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.2857142857142857
"ATYPICAL CHRONIC MYELOID LEUKEMIA, BCR-ABL1-",Atypical Chronic Myeloid Leukemia,0.6444444444444444,Recurrent Atypical Chronic Myeloid Leukemia,0.6000000000000001,Atypical Meningioma,0.30000000000000004,Atypical Fibroxanthoma,0.30000000000000004,Atypical Adenoma,0.30000000000000004
ATYPICAL LUNG CARCINOID,Atypical Adenomatous Lung Hyperplasia,0.4222222222222222,Spindle Cell Type Atypical Fibroxanthoma,0.4,Atypical Spindle Cell/Pleomorphic Lipomatous Tumor,0.38181818181818183,Lung Non-Small Cell Carcinoma,0.375,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,0.3666666666666667
B-CELL_ALL,Endometrial Mucosa-Associated Lymphoid Tissue Lymphoma,0.25,Bladder Mucosa-Associated Lymphoid Tissue Lymphoma,0.25,Breast Mucosa-Associated Lymphoid Tissue Lymphoma,0.25,Colon Mucosa-Associated Lymphoid Tissue Lymphoma,0.25,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0.25
BASALOID PENILE SQUAMOUS CELL CARCINOMA,Penile Basaloid Squamous Cell Carcinoma,0.9142857142857144,Basaloid Squamous Cell Carcinoma,0.7714285714285714,Vaginal Basaloid Squamous Cell Carcinoma,0.7,Vulvar Basaloid Squamous Cell Carcinoma,0.7,Cervical Basaloid Squamous Cell Carcinoma,0.7
BENIGN PT,Benign Breast Phyllodes Tumor,0.6444444444444444,Benign Mixed Tumor of the Vulva,0.5636363636363637,Benign Mixed Tumor of the Skin,0.5636363636363637,Benign Phyllodes Tumor,0.5333333333333333,Benign Prostate Phyllodes Tumor,0.5
BILIARY TRACT CANCER,Biliary Tract Carcinoma,0.4857142857142857,Metastatic Biliary Tract Carcinoma,0.45,Advanced Biliary Tract Carcinoma,0.45,Unresectable Biliary Tract Carcinoma,0.45,Refractory Biliary Tract Carcinoma,0.45
"BILIARY TRACT CANCER, NOS",Biliary Tract Carcinoma,0.5333333333333333,Metastatic Biliary Tract Carcinoma,0.4857142857142857,Advanced Biliary Tract Carcinoma,0.4857142857142857,Unresectable Biliary Tract Carcinoma,0.4857142857142857,Refractory Biliary Tract Carcinoma,0.4857142857142857
"BLADDER/URINARY TRACT CANCER, NOS",Stage IIA Bladder Cancer,0.4857142857142857,Stage IIB Bladder Cancer,0.4857142857142857,Stage IVA Bladder Cancer,0.4857142857142857,Stage IVB Bladder Cancer,0.4857142857142857,Stage 0is Bladder Cancer AJCC v8,0.4222222222222222
BLAST_PHASE_CHRONIC_MYELOID_LEUKAEMIA,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,0.2,Chronic Leukemia,0.18181818181818182,Lymphoid Leukemia,0.18181818181818182,Refractory Chronic Leukemia,0.16666666666666666,Recurrent Chronic Leukemia,0.16666666666666666
BLCA,Muscle Invasive Bladder Urothelial Carcinoma,0.45454545454545453,Recurrent Muscle Invasive Bladder Urothelial Carcinoma,0.4166666666666667,Localized Muscle Invasive Bladder Urothelial Carcinoma,0.4166666666666667,Invasive Bladder Urothelial Carcinoma,0.36363636363636365,Muscle Invasive Bladder Carcinoma,0.36363636363636365
BLOOD CANCER,Blood Vessel Neoplasm,0.27692307692307694,Malignant Blood Vessel Neoplasm,0.27142857142857146,Intermediate Blood Vessel Neoplasm,0.27142857142857146,Benign Blood Vessel Neoplasm,0.27142857142857146,Intermediate (Locally Aggressive) Blood Vessel Neoplasm,0.2625
"BLOOD CANCER, NOS",Blood Vessel Neoplasm,0.4857142857142857,Malignant Blood Vessel Neoplasm,0.45,Intermediate Blood Vessel Neoplasm,0.45,Benign Blood Vessel Neoplasm,0.45,Intermediate (Locally Aggressive) Blood Vessel Neoplasm,0.4
BORDERLINE PT,Borderline Breast Phyllodes Tumor,0.6444444444444444,Borderline Phyllodes Tumor,0.5333333333333333,Borderline Vulvar Phyllodes Tumor,0.5,Pulmonary Mucinous Cystic Tumor of Borderline Malignancy,0.4307692307692308,Borderline Ovarian Brenner Tumor,0.38181818181818183
BRCA,Invasive Breast Carcinoma,0.4,BRCA-Associated Breast Carcinoma,0.3666666666666667,Metastatic BRCA-Associated Breast Carcinoma,0.34285714285714286,Invasive Breast Papillary Carcinoma,0.3333333333333333,Invasive Breast Micropapillary Carcinoma,0.3333333333333333
BRCA_LUMA,Invasive Breast Lobular Carcinoma,0.5,"Invasive Breast Lobular Carcinoma, Alveolar Variant",0.4,"Invasive Breast Lobular Carcinoma, Pleomorphic Variant",0.4,"Invasive Breast Lobular Carcinoma, Solid Variant",0.4,"Invasive Breast Lobular Carcinoma, Tubulolobular Variant",0.4
BRCA_LUMB,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.4,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.4,Breast Ductal Carcinoma,0.375,Invasive Breast Carcinoma,0.375,Breast Paget Disease with Invasive Ductal Carcinoma,0.36363636363636365
BRCA_NORMAL,Invasive Breast Carcinoma,0.375,Invasive Breast Papillary Carcinoma,0.3333333333333333,Invasive Breast Micropapillary Carcinoma,0.3333333333333333,Invasive Female Breast Carcinoma,0.3333333333333333,Invasive Male Breast Carcinoma,0.3333333333333333
"BREAST INVASIVE CARCINOSARCOMA, NOS",Invasive Breast Carcinoma,0.45,Invasive Breast Papillary Carcinoma,0.4222222222222222,Invasive Breast Micropapillary Carcinoma,0.4222222222222222,Invasive Female Breast Carcinoma,0.4222222222222222,Invasive Male Breast Carcinoma,0.4222222222222222
BREAST INVASIVE DUCTAL CARCINOMA,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.6444444444444444,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.6444444444444444,Breast Ductal Carcinoma,0.6285714285714286,Invasive Breast Carcinoma,0.6285714285714286,Breast Paget Disease with Invasive Ductal Carcinoma,0.6000000000000001
BRONCHIOALVEOLAR_CARCINOMA,Lung Non-Small Cell Carcinoma,0.4,Childhood Lung Non-Small Cell Carcinoma,0.36363636363636365,Refractory Lung Non-Small Cell Carcinoma,0.36363636363636365,Advanced Lung Non-Small Cell Carcinoma,0.36363636363636365,Metastatic Lung Non-Small Cell Carcinoma,0.36363636363636365
BRONCHIOLOALVEOLAR_ADENOCARCINOMA,Lung Non-Small Cell Carcinoma,0.375,Lung Non-Small Cell Cancer by AJCC v7 Stage,0.36363636363636365,Stage IV Lung Non-Small Cell Cancer AJCC v7,0.36363636363636365,Stage I Lung Non-Small Cell Cancer AJCC v7,0.36363636363636365,Stage II Lung Non-Small Cell Cancer AJCC v7,0.36363636363636365
B_CELL_MEDIASTINAL_LARGE,Diffuse Large B-Cell Lymphoma,0.36363636363636365,Prostate Diffuse Large B-Cell Lymphoma,0.3333333333333333,Testicular Diffuse Large B-Cell Lymphoma,0.3333333333333333,Kidney Diffuse Large B-Cell Lymphoma,0.3333333333333333,Breast Diffuse Large B-Cell Lymphoma,0.3333333333333333
CANCER OF UNKNOWN PRIMARY,Major Salivary Gland Cancer by AJCC v7 Stage,0.4,Stage I Major Salivary Gland Cancer AJCC v7,0.4,Stage II Major Salivary Gland Cancer AJCC v7,0.4,Stage III Major Salivary Gland Cancer AJCC v7,0.4,Stage IV Major Salivary Gland Cancer AJCC v7,0.4
"CANCER OF UNKNOWN PRIMARY, NOS",Stage I Liver Cancer,0.4222222222222222,Stage II Liver Cancer,0.4222222222222222,Stage III Liver Cancer,0.4222222222222222,Stage IV Liver Cancer,0.4222222222222222,Stage IVA Liver Cancer,0.4222222222222222
CARCINOID,Carcinoid Tumor of Uncertain Malignant Potential,0.35384615384615387,Strumal Carcinoid,0.30000000000000004,Adenocarcinoma of Unknown Primary,0.3,Carcinoma of Unknown Primary,0.3,Melanoma of Unknown Primary,0.3
CARCINOID TUMOR,Laryngeal Carcinoid Tumor,0.7,Ovarian Insular Carcinoid Tumor,0.6000000000000001,Ovarian Trabecular Carcinoid Tumor,0.6000000000000001,Ovarian Mucinous Carcinoid Tumor,0.6000000000000001,Ovarian Teratoma with Carcinoid Tumor,0.5333333333333333
CARCINOID-ENDOCRINE TUMOUR,Adenocarcinoma of Unknown Primary,0.2727272727272727,Carcinoma of Unknown Primary,0.2727272727272727,Melanoma of Unknown Primary,0.2727272727272727,Neuroendocrine Carcinoma of Unknown Primary,0.25,Resectable Carcinoma of Unknown Primary,0.25
CARCINOMA WITH SQUAMOUS DIFFERENTIATION,Gallbladder Squamous Cell Carcinoma,0.7,Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation,0.7,Invasive Urothelial Carcinoma with Squamous Differentiation,0.6000000000000001,Ampulla of Vater Squamous Cell Carcinoma,0.6000000000000001,Floor of Mouth Squamous Cell Carcinoma,0.6000000000000001
CARCINOSARCOMA-MAMMARY GLAND,Invasive Breast Carcinoma,0.42857142857142855,Invasive Breast Papillary Carcinoma,0.375,Invasive Breast Micropapillary Carcinoma,0.375,Invasive Female Breast Carcinoma,0.375,Invasive Male Breast Carcinoma,0.375
CARCINOSARCOMA-MAMMARY GLAND; BREAST,Invasive Breast Carcinoma,0.42857142857142855,Invasive Breast Papillary Carcinoma,0.375,Invasive Breast Micropapillary Carcinoma,0.375,Invasive Female Breast Carcinoma,0.375,Invasive Male Breast Carcinoma,0.375
CCOV,Ovarian Clear Cell Adenocarcinoma,0.5,Advanced Ovarian Clear Cell Adenocarcinoma,0.4444444444444444,Metastatic Ovarian Clear Cell Adenocarcinoma,0.4444444444444444,Refractory Ovarian Clear Cell Adenocarcinoma,0.4444444444444444,Recurrent Ovarian Clear Cell Adenocarcinoma,0.4444444444444444
CESC,Cervical Squamous Cell Carcinoma,0.6666666666666666,Metastatic Cervical Squamous Cell Carcinoma,0.5714285714285714,Advanced Cervical Squamous Cell Carcinoma,0.5714285714285714,Refractory Cervical Squamous Cell Carcinoma,0.5714285714285714,Unresectable Cervical Squamous Cell Carcinoma,0.5714285714285714
CESC_SQUAMOUSCARCINOMA,Cervical Squamous Cell Carcinoma,0.5,Metastatic Cervical Squamous Cell Carcinoma,0.4444444444444444,Advanced Cervical Squamous Cell Carcinoma,0.4444444444444444,Refractory Cervical Squamous Cell Carcinoma,0.4444444444444444,Unresectable Cervical Squamous Cell Carcinoma,0.4444444444444444
CHOL EXTRA,Cholangiocarcinoma,0.3111111111111111,Advanced Cholangiocarcinoma,0.30000000000000004,Metastatic Cholangiocarcinoma,0.30000000000000004,Unresectable Cholangiocarcinoma,0.30000000000000004,Refractory Cholangiocarcinoma,0.30000000000000004
CHOLANGIOCARCINOMA; DISTAL,Cholangiocarcinoma,0.3666666666666667,Advanced Cholangiocarcinoma,0.34285714285714286,Metastatic Cholangiocarcinoma,0.34285714285714286,Unresectable Cholangiocarcinoma,0.34285714285714286,Refractory Cholangiocarcinoma,0.34285714285714286
CHRONIC MYELOGENOUS LEUKEMIA,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,0.4,Chronic Leukemia,0.38181818181818183,Refractory Chronic Leukemia,0.3666666666666667,Recurrent Chronic Leukemia,0.3666666666666667,Chronic Lymphocytic Leukemia,0.3666666666666667
"CHRONIC MYELOID LEUKEMIA, BCR-ABL1+",Atypical Chronic Myeloid Leukemia,0.6000000000000001,Recurrent Atypical Chronic Myeloid Leukemia,0.5636363636363637,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.5636363636363637,"Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.5333333333333333,"Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.5333333333333333
CHRONIC_MYELOID_LEUKAEMIA,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,0.1875,Chronic Leukemia,0.16666666666666666,Lymphoid Leukemia,0.16666666666666666,Refractory Chronic Leukemia,0.15384615384615385,Recurrent Chronic Leukemia,0.15384615384615385
CLASSICAL HCA,Classical Glioblastoma,0.325,Classical Burkitt Lymphoma,0.3111111111111111,Classical Low Grade Fibromyxoid Sarcoma,0.2909090909090909,Hepatocellular Adenoma,0.2857142857142857,HNF1alpha-Inactivated Hepatocellular Adenoma,0.25
CLEAR CELL PAPILLARY RENAL CELL CARCINOMA,Clear Cell Renal Cell Carcinoma,0.8666666666666667,Advanced Clear Cell Renal Cell Carcinoma,0.7714285714285714,Metastatic Clear Cell Renal Cell Carcinoma,0.7714285714285714,Refractory Clear Cell Renal Cell Carcinoma,0.7714285714285714,Recurrent Clear Cell Renal Cell Carcinoma,0.7714285714285714
CML,Atypical Chronic Myeloid Leukemia,0.4,Recurrent Atypical Chronic Myeloid Leukemia,0.36363636363636365,Myelodysplastic Chronic Myelomonocytic Leukemia,0.2727272727272727,Myeloproliferative Chronic Myelomonocytic Leukemia,0.2727272727272727,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm,0.26666666666666666
CNS,Childhood Acute Lymphoblastic Leukemia CNS 1 Toronto Guidelines v2,0.3666666666666667,Childhood Acute Lymphoblastic Leukemia CNS 2 Toronto Guidelines v2,0.3666666666666667,Childhood Acute Lymphoblastic Leukemia CNS 3 Toronto Guidelines v2,0.3666666666666667,B Lymphoblastic Leukemia/Lymphoma,0.2857142857142857,Adult T-Cell Leukemia/Lymphoma,0.2857142857142857
CNS CANCER,Childhood Acute Lymphoblastic Leukemia CNS 1 Toronto Guidelines v2,0.25882352941176473,Childhood Acute Lymphoblastic Leukemia CNS 2 Toronto Guidelines v2,0.25882352941176473,Childhood Acute Lymphoblastic Leukemia CNS 3 Toronto Guidelines v2,0.25882352941176473,Posterior Fossa Ependymoma,0.2,Posterior Fossa Neoplasm,0.2
COAD,Colorectal Adenocarcinoma,0.2857142857142857,Metastatic Colorectal Adenocarcinoma,0.25,Advanced Colorectal Adenocarcinoma,0.25,Refractory Colorectal Adenocarcinoma,0.25,Unresectable Colorectal Adenocarcinoma,0.25
COAD_GS,Colon Adenocarcinoma,0.3333333333333333,Colorectal Adenocarcinoma,0.3333333333333333,Refractory Colon Adenocarcinoma,0.2857142857142857,Metastatic Colon Adenocarcinoma,0.2857142857142857,Advanced Colon Adenocarcinoma,0.2857142857142857
COLON ADENOCARCINOMA IN SITU,Colon Adenocarcinoma,0.45,Refractory Colon Adenocarcinoma,0.4222222222222222,Metastatic Colon Adenocarcinoma,0.4222222222222222,Advanced Colon Adenocarcinoma,0.4222222222222222,Unresectable Colon Adenocarcinoma,0.4222222222222222
COLORECTAL HYPERMUTATED,Colorectal Adenocarcinoma,0.4857142857142857,Metastatic Colorectal Adenocarcinoma,0.45,Advanced Colorectal Adenocarcinoma,0.45,Refractory Colorectal Adenocarcinoma,0.45,Hypermutated Colorectal Carcinoma,0.45
CONGENITAL FIBROSARCOMA,Congenital Hemangioma,0.4,Congenital Mesoblastic Nephroma,0.3666666666666667,Liver Congenital Hemangioma,0.3666666666666667,Congenital Melanocytic Nevus,0.3666666666666667,Congenital Cystic Hygroma,0.3666666666666667
CRC HM,Cecum Adenocarcinoma,0.2222222222222222,Colon Adenocarcinoma,0.2222222222222222,Colorectal Adenocarcinoma,0.2222222222222222,Refractory Colon Adenocarcinoma,0.2,Metastatic Colon Adenocarcinoma,0.2
CSCC,Cutaneous Merkel Cell Carcinoma,0.5333333333333333,Cutaneous Squamous Cell Carcinoma of the Head and Neck,0.5076923076923077,Skin Squamous Cell Carcinoma,0.5,Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck,0.4857142857142857,Refractory Cutaneous Squamous Cell Carcinoma of the Head and Neck,0.4857142857142857
CUTANEOUS MALIGNANCY OF HAIR MATRIX CELLS,Cutaneous Squamous Cell Carcinoma of the Head and Neck,0.3875,Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck,0.3764705882352941,Refractory Cutaneous Squamous Cell Carcinoma of the Head and Neck,0.3764705882352941,Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck,0.3764705882352941,Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck,0.3764705882352941
DEDIFFERENTIATED,Dedifferentiated Chondrosarcoma,0.6000000000000001,Dedifferentiated Chordoma,0.3666666666666667,Dedifferentiated Leiomyosarcoma,0.3666666666666667,Dedifferentiated Liposarcoma,0.3666666666666667,Ovarian Dedifferentiated Carcinoma,0.34285714285714286
DERMATOFIBROMA,Stage 0 Skin Cancer,0.2857142857142857,Stage I Skin Cancer,0.2857142857142857,Stage II Skin Cancer,0.2857142857142857,Stage III Skin Cancer,0.2857142857142857,Stage IV Skin Cancer,0.2857142857142857
DUCTAL/NST,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.6444444444444444,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.6444444444444444,Breast Ductal Carcinoma,0.6285714285714286,Breast Paget Disease with Invasive Ductal Carcinoma,0.6000000000000001,Metastatic Breast Ductal Carcinoma,0.575
EARLY T-CELL PRECURSOR LYMPHOBLASTIC LEUKEMIA,Early T Precursor Lymphoblastic Leukemia/Lymphoma,0.7555555555555555,Early T Precursor Acute Lymphoblastic Leukemia,0.6000000000000001,Early T Precursor Acute Lymphoblastic Leukemia with BCL11B Rearrangement,0.5076923076923077,"Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.5076923076923077,Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.4727272727272727
EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES,Embryonal Tumor with Multilayered Rosettes,0.6000000000000001,"Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated",0.5636363636363637,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5636363636363637,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5333333333333333,Stage M0 Embryonal Tumor with Multilayered Rosettes,0.5333333333333333
EMBT,Central Nervous System Embryonal Tumor,0.3333333333333333,Embryonal Tumor with Multilayered Rosettes,0.3333333333333333,Childhood Central Nervous System Embryonal Tumor,0.2857142857142857,"Cerebral Embryonal Tumor, Not Otherwise Specified",0.2857142857142857,"Supratentorial Embryonal Tumor, Not Otherwise Specified",0.2857142857142857
ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE,"Endocervical Adenocarcinoma, Usual-Type",0.4,"Recurrent Endocervical Adenocarcinoma, Usual-Type",0.38181818181818183,Endocervical Polyp,0.30000000000000004,"Cervical Adenomyoma, Endocervical-Type",0.2909090909090909,Endocervical Undifferentiated Sarcoma,0.2909090909090909
EPENDYMOBLASTOMA,Central Nervous System Embryonal Tumor,0.2857142857142857,Embryonal Tumor with Multilayered Rosettes,0.2857142857142857,Childhood Central Nervous System Embryonal Tumor,0.25,"Cerebral Embryonal Tumor, Not Otherwise Specified",0.25,"Supratentorial Embryonal Tumor, Not Otherwise Specified",0.25
EPITHELIOID CELL TUMOR,Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.45,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.4307692307692308,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.4307692307692308,Epithelioid Sarcoma,0.4222222222222222,Vulvar Epithelioid Sarcoma,0.4
ESCA,Esophageal Adenocarcinoma,0.25,Unresectable Esophageal Adenocarcinoma,0.2222222222222222,Metastatic Esophageal Adenocarcinoma,0.2222222222222222,Oligometastatic Esophageal Adenocarcinoma,0.2222222222222222,Advanced Esophageal Adenocarcinoma,0.2222222222222222
ESCA_GS,Esophageal Adenocarcinoma,0.25,Unresectable Esophageal Adenocarcinoma,0.2222222222222222,Metastatic Esophageal Adenocarcinoma,0.2222222222222222,Oligometastatic Esophageal Adenocarcinoma,0.2222222222222222,Advanced Esophageal Adenocarcinoma,0.2222222222222222
ESOPHAGUS/STOMACH,Thoracic Esophagus Squamous Cell Carcinoma,0.5333333333333333,Cervical Esophagus Squamous Cell Carcinoma,0.5333333333333333,Distal Esophagus Squamous Cell Carcinoma,0.5333333333333333,Lung Non-Small Cell Squamous Carcinoma,0.45454545454545453,Refractory Lung Non-Small Cell Squamous Carcinoma,0.4166666666666667
ETMR,Embryonal Tumor with Multilayered Rosettes,0.36363636363636365,"Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated",0.3333333333333333,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.3333333333333333,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.3076923076923077,Stage M0 Embryonal Tumor with Multilayered Rosettes,0.3076923076923077
ETP-ALL,Early T Precursor Lymphoblastic Leukemia/Lymphoma,0.5,Early T Precursor Acute Lymphoblastic Leukemia,0.36363636363636365,B Lymphoblastic Leukemia/Lymphoma,0.3,Adult T-Cell Leukemia/Lymphoma,0.3,T Lymphoblastic Leukemia/Lymphoma,0.3
EWING-LIKE SARCOMA,Sarcoma,0.5,Vaginal Sarcoma,0.3333333333333333,Ovarian Sarcoma,0.3333333333333333,Vulvar Sarcoma,0.3333333333333333,Prostate Sarcoma,0.3333333333333333
EXTRA-ADRENAL PHEOCHROMOCYTOMA,Extra-Adrenal Paraganglioma,0.4857142857142857,Metastatic Extra-Adrenal Paraganglioma,0.45,Extra-Adrenal Sympathetic Paraganglioma,0.45,Extra-Adrenal Retroperitoneal Paraganglioma,0.45,Dysembryoplastic Neuroepithelial Tumor,0.25
EXTRAHEPATIC CHOLANGIOCARCINOMA,Stage 0 Extrahepatic Bile Duct Cancer,0.4222222222222222,Stage I Extrahepatic Bile Duct Cancer,0.4222222222222222,Stage II Extrahepatic Bile Duct Cancer,0.4222222222222222,Stage III Extrahepatic Bile Duct Cancer,0.4222222222222222,Stage IV Extrahepatic Bile Duct Cancer,0.4222222222222222
"FOLLICULAR, PAPILLARY",Follicular Variant Thyroid Gland Papillary Carcinoma,0.5636363636363637,Thyroid Gland Papillary and Follicular Carcinoma,0.5636363636363637,Invasive Follicular Variant Thyroid Gland Papillary Carcinoma,0.5333333333333333,Invasive Encapsulated Follicular Variant Thyroid Gland Papillary Carcinoma,0.5076923076923077,Thyroid Gland Follicular Carcinoma,0.5
GINET,Liver Neuroendocrine Tumor,0.42857142857142855,Liver Neuroendocrine Tumor G1,0.375,Liver Neuroendocrine Tumor G3,0.375,Liver Neuroendocrine Tumor G2,0.375,Neuroendocrine Tumor,0.2857142857142857
"GLIOBLASTOMA, IDH-MUTANT",Glioblastoma,0.45,Recurrent Glioblastoma,0.4,Childhood Glioblastoma,0.4,Unresectable Glioblastoma,0.4,Proneural Glioblastoma,0.4
GLIONEURONAL TUMOR,Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle,1.075,Rosette-Forming Glioneuronal Tumor,0.575,Myxoid Glioneuronal Tumor of the Septum Pellucidum,0.5636363636363637,Myxoid Glioneuronal Tumor,0.4222222222222222,Papillary Glioneuronal Tumor,0.4222222222222222
GLOMANGIOSARCOMA,Soft Tissue Sarcoma,0.75,Laryngeal Soft Tissue Sarcoma,0.6,Childhood Soft Tissue Sarcoma,0.6,Recurrent Soft Tissue Sarcoma,0.6,Refractory Soft Tissue Sarcoma,0.6
HEAD & NECK SQUAMOUS CELL CARCINOMA BASALOID TYPE,Head and Neck Basaloid Squamous Cell Carcinoma,0.8999999999999999,Head and Neck Squamous Cell Carcinoma,0.8,Recurrent Head and Neck Squamous Cell Carcinoma,0.7454545454545454,Refractory Head and Neck Squamous Cell Carcinoma,0.7454545454545454,Advanced Head and Neck Squamous Cell Carcinoma,0.7454545454545454
HEAD AND NECK CARCINOMA OTHER,Head and Neck Carcinoma,1.0,Head and Neck Neuroendocrine Carcinoma,0.8666666666666667,Recurrent Head and Neck Carcinoma,0.8666666666666667,Refractory Head and Neck Carcinoma,0.8666666666666667,Platinum-Resistant Head and Neck Carcinoma,0.8666666666666667
"HEAD AND NECK CARCINOMA, OTHER",Head and Neck Carcinoma,0.7,Head and Neck Neuroendocrine Carcinoma,0.6444444444444444,Recurrent Head and Neck Carcinoma,0.6444444444444444,Refractory Head and Neck Carcinoma,0.6444444444444444,Platinum-Resistant Head and Neck Carcinoma,0.6444444444444444
HEAD AND NECK SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY,Head and Neck Carcinoma of Unknown Primary,0.7384615384615385,Cutaneous Squamous Cell Carcinoma of the Head and Neck,0.6666666666666667,Head and Neck Squamous Cell Carcinoma,0.6615384615384616,Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck,0.6375,Refractory Cutaneous Squamous Cell Carcinoma of the Head and Neck,0.6375
HEMANGIOPERICYTOMA OF THE CENTRAL NERVOUS SYSTEM,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.3333333333333333,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.3125,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.3125,AIDS-Related Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.3125,Metastatic Melanoma in the Central Nervous System,0.3076923076923077
HEPATOBILIARY CANCER,Intrahepatic Cholangiocarcinoma,0.4,Hepatobiliary Neoplasm,0.3666666666666667,Malignant Hepatobiliary Neoplasm,0.34285714285714286,Metastatic Intrahepatic Cholangiocarcinoma,0.3333333333333333,Advanced Intrahepatic Cholangiocarcinoma,0.3333333333333333
HGGNOS,Glioma,0.2,Recurrent Glioma,0.16666666666666666,Diffuse Glioma,0.16666666666666666,Mixed Glioma,0.16666666666666666,Angiocentric Glioma,0.16666666666666666
HNSC,Head and Neck Squamous Cell Carcinoma,0.6,Recurrent Head and Neck Squamous Cell Carcinoma,0.5454545454545454,Refractory Head and Neck Squamous Cell Carcinoma,0.5454545454545454,Advanced Head and Neck Squamous Cell Carcinoma,0.5454545454545454,Metastatic Head and Neck Squamous Cell Carcinoma,0.5454545454545454
HURTHLE,Thyroid Gland Langerhans Cell Histiocytosis,0.25,Thyroid Gland Spindle Cell Follicular Adenoma,0.2222222222222222,Thyroid Gland Clear Cell Follicular Adenoma,0.2222222222222222,Thyroid Gland Follicular Dendritic Cell Sarcoma,0.2222222222222222,Thyroid Gland Undifferentiated Small Cell Carcinoma,0.2222222222222222
HYPOPHARYNGEAL,Hypopharyngeal Squamous Cell Carcinoma,0.5333333333333333,Recurrent Hypopharyngeal Squamous Cell Carcinoma,0.5076923076923077,Metastatic Hypopharyngeal Squamous Cell Carcinoma,0.5076923076923077,Advanced Hypopharyngeal Squamous Cell Carcinoma,0.5076923076923077,Refractory Hypopharyngeal Squamous Cell Carcinoma,0.5076923076923077
IDC,Breast Ductal Carcinoma,0.42857142857142855,Metastatic Breast Ductal Carcinoma,0.375,Breast Ductal Carcinoma In Situ,0.3333333333333333,Recurrent Breast Ductal Carcinoma In Situ,0.3,Breast Papillary Ductal Carcinoma In Situ,0.3
INFANTILE SARCOMA,Soft Tissue Sarcoma,0.75,Laryngeal Soft Tissue Sarcoma,0.6,Childhood Soft Tissue Sarcoma,0.6,Recurrent Soft Tissue Sarcoma,0.6,Refractory Soft Tissue Sarcoma,0.6
INFILTRATING DUCTAL & LOBULAR,Breast Mixed Ductal and Lobular Carcinoma,0.5,Infiltrating Ureter Urothelial Carcinoma with Mixed Differentiation,0.3875,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.38461538461538464,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.38461538461538464,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.35714285714285715
INFILTRATING DUCTAL CARCINOMA,Breast Ductal Carcinoma,0.42857142857142855,Skin Infiltrating Basal Cell Carcinoma,0.4,Metastatic Breast Ductal Carcinoma,0.375,Infiltrating Ureter Urothelial Carcinoma with Mixed Differentiation,0.3666666666666667,Breast Ductal Carcinoma In Situ,0.3333333333333333
INITIAL CNS TUMOR,Atypical Teratoid/Rhabdoid Tumor,0.36363636363636365,Recurrent Atypical Teratoid/Rhabdoid Tumor,0.3333333333333333,Childhood Atypical Teratoid/Rhabdoid Tumor,0.3333333333333333,Refractory Atypical Teratoid/Rhabdoid Tumor,0.3333333333333333,Stage M0 Atypical Teratoid/Rhabdoid Tumor,0.3076923076923077
INVASIVE_DUCTAL_CARCINOMA,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.4444444444444444,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.4444444444444444,Breast Ductal Carcinoma,0.42857142857142855,Invasive Breast Carcinoma,0.42857142857142855,Breast Paget Disease with Invasive Ductal Carcinoma,0.4
KICH,Non-Clear Cell Renal Cell Carcinoma,0.5,Chromophobe Renal Cell Carcinoma,0.5,Advanced Chromophobe Renal Cell Carcinoma,0.4444444444444444,Metastatic Chromophobe Renal Cell Carcinoma,0.4444444444444444,Recurrent Chromophobe Renal Cell Carcinoma,0.4444444444444444
KIRC,Clear Cell Renal Cell Carcinoma,0.5714285714285714,Advanced Clear Cell Renal Cell Carcinoma,0.5,Metastatic Clear Cell Renal Cell Carcinoma,0.5,Refractory Clear Cell Renal Cell Carcinoma,0.5,Recurrent Clear Cell Renal Cell Carcinoma,0.5
KIRP,Non-Clear Cell Renal Cell Carcinoma,0.5,Papillary Renal Cell Carcinoma,0.5,Advanced Papillary Renal Cell Carcinoma,0.4444444444444444,Metastatic Papillary Renal Cell Carcinoma,0.4444444444444444,Unresectable Papillary Renal Cell Carcinoma,0.4444444444444444
LAML,Acute Myeloid Leukemia,0.6,Refractory Acute Myeloid Leukemia,0.5,Recurrent Acute Myeloid Leukemia,0.5,Secondary Acute Myeloid Leukemia,0.5,Benzene-Related Acute Myeloid Leukemia,0.5
LGSOC,Ovarian Low Grade Serous Adenocarcinoma,0.5,Refractory Ovarian Low Grade Serous Adenocarcinoma,0.45454545454545453,Recurrent Ovarian Low Grade Serous Adenocarcinoma,0.45454545454545453,Ovarian High Grade Serous Adenocarcinoma,0.36363636363636365,Ovarian Low Grade Endometrioid Adenocarcinoma,0.36363636363636365
LIHB,Stage I Liver Cancer,0.25,Stage II Liver Cancer,0.25,Stage III Liver Cancer,0.25,Stage IV Liver Cancer,0.25,Stage IVA Liver Cancer,0.25
LIHC,Liver Carcinoma,0.2857142857142857,Hepatocellular Carcinoma,0.2857142857142857,Liver Neuroendocrine Carcinoma,0.25,Childhood Hepatocellular Carcinoma,0.25,Metastatic Liver Carcinoma,0.25
LIPOFIBROMATOSIS-LIKE NEURAL TUMOR,Testicular Spermatocytic Tumor with Sarcoma,0.2857142857142857,Sarcoma,0.25,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.25,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,0.2222222222222222,Gastrointestinal Clear Cell Sarcoma/Malignant Gastrointestinal Neuroectodermal Tumor,0.2222222222222222
"LIVER CANCER, NOS",Liver Carcinoma,0.5333333333333333,Liver Neuroendocrine Carcinoma,0.4857142857142857,Metastatic Liver Carcinoma,0.4857142857142857,Unresectable Liver Carcinoma,0.4857142857142857,Liver Adenosquamous Carcinoma,0.4857142857142857
LIVER TUMOR,Liver Neuroendocrine Tumor,0.4857142857142857,Liver Neuroendocrine Tumor G1,0.45,Liver Neuroendocrine Tumor G3,0.45,Liver Neuroendocrine Tumor G2,0.45,Liver Solitary Fibrous Tumor,0.45
LIVER_CANCER,Liver Carcinoma,0.2857142857142857,Hepatocellular Carcinoma,0.2857142857142857,Liver Neuroendocrine Carcinoma,0.25,Childhood Hepatocellular Carcinoma,0.25,Metastatic Liver Carcinoma,0.25
LNET,Lung Neuroendocrine Tumor,0.42857142857142855,Advanced Lung Neuroendocrine Tumor,0.375,Metastatic Lung Neuroendocrine Tumor,0.375,Unresectable Lung Neuroendocrine Tumor,0.375,Lung Neuroendocrine Tumor G1,0.375
LOW HYPODIPLOID,Low Grade Lymphoma,0.4857142857142857,Low Grade T-Cell Lymphoma,0.45,Low Grade B-Cell Non-Hodgkin's Lymphoma,0.4,Primary Low Grade B-Cell Dural Lymphoma,0.4,Low Grade Adult Non-Hodgkin's Lymphoma,0.4
LOW-GRADE NEUROEPITHELIAL TUMOR,Dysembryoplastic Neuroepithelial Tumor,0.2857142857142857,Cribriform Neuroepithelial Tumor,0.2857142857142857,Childhood Dysembryoplastic Neuroepithelial Tumor,0.25,Adult Dysembryoplastic Neuroepithelial Tumor,0.25,Childhood Brain Germ Cell Tumor,0.2222222222222222
LUAD,Lung Non-Small Cell Carcinoma,0.4444444444444444,Childhood Lung Non-Small Cell Carcinoma,0.4,Refractory Lung Non-Small Cell Carcinoma,0.4,Advanced Lung Non-Small Cell Carcinoma,0.4,Metastatic Lung Non-Small Cell Carcinoma,0.4
LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS,Lung Non-Small Cell Carcinoma,0.6444444444444444,Childhood Lung Non-Small Cell Carcinoma,0.6000000000000001,Refractory Lung Non-Small Cell Carcinoma,0.6000000000000001,Advanced Lung Non-Small Cell Carcinoma,0.6000000000000001,Metastatic Lung Non-Small Cell Carcinoma,0.6000000000000001
LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS,Lung Non-Small Cell Carcinoma,0.6444444444444444,Childhood Lung Non-Small Cell Carcinoma,0.6000000000000001,Refractory Lung Non-Small Cell Carcinoma,0.6000000000000001,Advanced Lung Non-Small Cell Carcinoma,0.6000000000000001,Metastatic Lung Non-Small Cell Carcinoma,0.6000000000000001
LUNG CARCINOID,Lung Non-Small Cell Carcinoma,0.5333333333333333,Lung Non-Small Cell Cancer by AJCC v7 Stage,0.5333333333333333,Stage IV Lung Non-Small Cell Cancer AJCC v7,0.5333333333333333,Stage I Lung Non-Small Cell Cancer AJCC v7,0.5333333333333333,Stage II Lung Non-Small Cell Cancer AJCC v7,0.5333333333333333
LUNG NEUROENDOCRINE,Lung Neuroendocrine Tumor,0.6285714285714286,Advanced Lung Neuroendocrine Tumor,0.575,Metastatic Lung Neuroendocrine Tumor,0.575,Unresectable Lung Neuroendocrine Tumor,0.575,Lung Neuroendocrine Tumor G1,0.575
LUNG NEUROENDOCRINE TUMOR,Lung Neuroendocrine Tumor,0.6285714285714286,Advanced Lung Neuroendocrine Tumor,0.575,Metastatic Lung Neuroendocrine Tumor,0.575,Unresectable Lung Neuroendocrine Tumor,0.575,Lung Neuroendocrine Tumor G1,0.575
LUNG_CARCINOID,Lung Non-Small Cell Cancer by AJCC v7 Stage,0.3076923076923077,Stage IV Lung Non-Small Cell Cancer AJCC v7,0.3076923076923077,Stage I Lung Non-Small Cell Cancer AJCC v7,0.3076923076923077,Stage II Lung Non-Small Cell Cancer AJCC v7,0.3076923076923077,Stage III Lung Non-Small Cell Cancer AJCC v7,0.3076923076923077
LUSC,Lung Non-Small Cell Squamous Carcinoma,0.5555555555555556,Refractory Lung Non-Small Cell Squamous Carcinoma,0.5,Advanced Lung Non-Small Cell Squamous Carcinoma,0.5,Metastatic Lung Non-Small Cell Squamous Carcinoma,0.5,Unresectable Lung Non-Small Cell Squamous Carcinoma,0.5
"LYMPHATIC CANCER, NOS",Lymphatic Vessel Neoplasm,0.45,Benign Lymphatic Vessel Neoplasm,0.4222222222222222,Hematopoietic and Lymphatic System Neoplasm,0.4,Precursor Lymphoid Neoplasm,0.25,Cutaneous Precursor Lymphoid Neoplasm,0.2222222222222222
M0,Stage M0 Pineoblastoma,0.30000000000000004,Stage M0 Medulloblastoma,0.30000000000000004,Stage M0 Atypical Teratoid/Rhabdoid Tumor,0.27692307692307694,"Penile Squamous Cell Carcinoma, Usual Type",0.2727272727272727,Stage M0 Embryonal Tumor with Multilayered Rosettes,0.27142857142857146
M2,Stage M2 Embryonal Tumor with Multilayered Rosettes,0.38181818181818183,Acute Myeloid Leukemia with Maturation,0.375,Childhood Acute Myeloid Leukemia with Maturation,0.3333333333333333,Adult Acute Myeloid Leukemia with Maturation,0.3333333333333333,Stage M2 Pineoblastoma,0.325
M3,Stage M3 Embryonal Tumor with Multilayered Rosettes,0.38181818181818183,Stage M3 Pineoblastoma,0.325,Stage M3 Medulloblastoma,0.325,Stage M3 Atypical Teratoid/Rhabdoid Tumor,0.2909090909090909,Stage M3 Childhood Medulloblastoma by Toronto Guidelines v2,0.27692307692307694
M4,Salivary Gland Adenoid Cystic Carcinoma,0.4166666666666667,Minor Salivary Gland Adenoid Cystic Carcinoma,0.38461538461538464,Major Salivary Gland Adenoid Cystic Carcinoma,0.38461538461538464,Head and Neck Carcinoma,0.3333333333333333,Bartholin Gland Adenoid Cystic Carcinoma,0.3076923076923077
M5,Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A,0.4,Lymphoid Leukemia,0.3333333333333333,Acute Leukemia,0.3333333333333333,B-Cell Leukemia,0.3333333333333333,Refractory Acute Leukemia,0.2857142857142857
M6,Acute Myeloid Leukemia,0.6,Refractory Acute Myeloid Leukemia,0.5,Recurrent Acute Myeloid Leukemia,0.5,Secondary Acute Myeloid Leukemia,0.5,Benzene-Related Acute Myeloid Leukemia,0.5
M7,Acute Myeloid Leukemia with Biallelic CEBPA Mutation,0.3333333333333333,Acute Myeloid Leukemia with CEBPA Mutation,0.25,Acute Myeloid Leukemia with Germline CEBPA Mutation,0.23076923076923078,Acute Myeloid Leukemia with Monoallelic CEBPA Mutation,0.23076923076923078,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.23076923076923078
MALIGNANT FIBROUS HISTIOCYTOMA,Malignant Soft Tissue Neoplasm,0.4727272727272727,Malignant Cervical Soft Tissue Neoplasm,0.45,Malignant Sinonasal Soft Tissue Neoplasm,0.45,Malignant Laryngeal Soft Tissue Neoplasm,0.45,Malignant Mediastinal Soft Tissue Neoplasm,0.45
MALIGNANT PT,Malignant Breast Phyllodes Tumor,0.6444444444444444,Malignant Mixed Tumor of the Skin,0.5636363636363637,Malignant Mixed Tumor of the Salivary Gland,0.5333333333333333,Malignant Phyllodes Tumor,0.5333333333333333,Malignant Mixed Tumor of the Major Salivary Gland,0.5076923076923077
MALIGNANT_FIBROUS_HISTIOCYTOMA,Undifferentiated Soft Tissue Sarcoma,0.26666666666666666,Undifferentiated Spindle Cell Sarcoma,0.26666666666666666,Clear Cell Sarcoma of Soft Tissue,0.23529411764705882,Childhood Clear Cell Sarcoma of Soft Tissue,0.2222222222222222,Recurrent Clear Cell Sarcoma of Soft Tissue,0.2222222222222222
MASKED LOW HYPODIPLOID,Hypodiploid B Lymphoblastic Leukemia/Lymphoma,0.3333333333333333,Low Grade Lymphoma,0.25,B Lymphoblastic Leukemia/Lymphoma,0.2222222222222222,Adult T-Cell Leukemia/Lymphoma,0.2222222222222222,T Lymphoblastic Leukemia/Lymphoma,0.2222222222222222
MBL,Muscle Invasive Bladder Urothelial Carcinoma,0.4166666666666667,Recurrent Muscle Invasive Bladder Urothelial Carcinoma,0.38461538461538464,Localized Muscle Invasive Bladder Urothelial Carcinoma,0.38461538461538464,Invasive Bladder Urothelial Carcinoma,0.3333333333333333,Muscle Invasive Bladder Carcinoma,0.3333333333333333
MDS WITH EXCESS BLASTS-2,Myelodysplastic Syndrome with Excess Blasts,0.3333333333333333,Childhood Myelodysplastic Syndrome with Excess Blasts,0.3,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,0.2727272727272727,Myelodysplastic Syndrome with Mutated TP53,0.2,Myelodysplastic Syndrome with Low Blasts,0.2
MDS WITH MULTILINEAGE DYSPLASIA,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.36363636363636365,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.36363636363636365,Acute Myeloid Leukemia with Multilineage Dysplasia,0.3,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,0.2727272727272727,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.2727272727272727
MDS WITH SINGLE LINEAGE DYSPLASIA,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.5,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.4166666666666667,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.4166666666666667,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.23076923076923078,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.23076923076923078
MDS/MPN WITH RING SIDEROBLASTS AND THROMBOCYTOSIS,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",0.4117647058823529,Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis,0.3125,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.3125,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.29411764705882354,Myelodysplastic Syndrome with Ring Sideroblasts,0.2857142857142857
"MDS/MPN, UNCLASSIFIABLE",Myelodysplastic/Myeloproliferative Neoplasm,0.25,"Myelodysplastic Syndrome, Unclassifiable",0.25,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.2222222222222222,Recurrent Myelodysplastic/Myeloproliferative Neoplasm,0.2222222222222222,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.18181818181818182
MEDULLARY,Kidney Medullary Carcinoma,0.4857142857142857,Breast Medullary Carcinoma,0.4857142857142857,Colon Medullary Carcinoma,0.4857142857142857,Rectal Medullary Carcinoma,0.4857142857142857,Colorectal Medullary Carcinoma,0.4857142857142857
MED_GROUP_3,Central Nervous System Embryonal Tumor,0.2,Embryonal Tumor with Multilayered Rosettes,0.2,Childhood Central Nervous System Embryonal Tumor,0.18181818181818182,"Cerebral Embryonal Tumor, Not Otherwise Specified",0.18181818181818182,"Supratentorial Embryonal Tumor, Not Otherwise Specified",0.18181818181818182
MENINGOTHELIAL TUMOR,Meningothelial Meningioma,0.3666666666666667,Meningothelial Cell Neoplasm,0.34285714285714286,"Malignant Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",0.2,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",0.2,"Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",0.2
METASTATIC CARCINOMA,Metastatic Prostate Carcinoma,0.95,Metastatic Prostate Neuroendocrine Carcinoma,0.8,Metastatic Carcinoma,0.7,Metastatic Prostate Small Cell Neuroendocrine Carcinoma,0.6285714285714286,Prostate Carcinoma Metastatic in the Lung,0.6285714285714286
METASTATIC HORMONE-SENSITIVE,Metastatic Prostate Adenocarcinoma,0.7,Metastatic Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.5333333333333333,Metastatic Adenocarcinoma,0.5333333333333333,Metastatic Cervical Adenocarcinoma,0.4857142857142857,Metastatic Bladder Adenocarcinoma,0.4857142857142857
"METASTATIC, VARIANT HISTOLOGY",Metastatic Prostate Adenocarcinoma,0.6285714285714286,Metastatic Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.5,Metastatic Adenocarcinoma,0.4857142857142857,Metastatic Cervical Adenocarcinoma,0.45,Metastatic Bladder Adenocarcinoma,0.45
METATYPICAL,Stage 0 Skin Cancer,0.2857142857142857,Stage I Skin Cancer,0.2857142857142857,Stage II Skin Cancer,0.2857142857142857,Stage III Skin Cancer,0.2857142857142857,Stage IV Skin Cancer,0.2857142857142857
MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA,Renal Cell Carcinoma with MiT Translocations,0.6444444444444444,Childhood Renal Cell Carcinoma with MiT Translocations,0.6000000000000001,Renal Cell Carcinoma,0.42857142857142855,Limited Stage Lung Small Cell Carcinoma,0.38181818181818183,Advanced Renal Cell Carcinoma,0.375
MIXED 80% ALVEOLAR,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.45,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.4307692307692308,Soft Tissue Sarcoma,0.375,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,0.35384615384615387,Laryngeal Soft Tissue Sarcoma,0.3333333333333333
MIXED ACINAR-NEUROENDOCRINE CARCINOMA,Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma,0.5333333333333333,Pancreatic Mixed Adenoneuroendocrine Carcinoma,0.45,Pancreatic Mixed Acinar-Ductal Carcinoma,0.45,Penile Mixed Squamous Cell Carcinoma,0.4307692307692308,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma,0.4307692307692308
"MIXED PHENOTYPE ACUTE LEUKAEMIA, T/MYELOID, NOS","Mixed Phenotype Acute Leukemia, T/Myeloid",0.8666666666666667,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",0.8,"Mixed Phenotype Acute Leukemia, B/T",0.7,"Mixed Phenotype Acute Leukemia, T/Megakaryocytic",0.7,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.7
"MIXED PHENOTYPE ACUTE LEUKEMIA, B/MYELOID, NOS","Mixed Phenotype Acute Leukemia, B/Myeloid",0.95,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",0.8666666666666667,"Mixed Phenotype Acute Leukemia, B/T",0.7555555555555555,"Mixed Phenotype Acute Leukemia, T/Myeloid",0.7555555555555555,Mixed Phenotype Acute Leukemia,0.7
"MIXED PHENOTYPE ACUTE LEUKEMIA, T/MYELOID, NOS","Mixed Phenotype Acute Leukemia, T/Myeloid",0.95,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",0.8666666666666667,"Mixed Phenotype Acute Leukemia, B/T",0.7555555555555555,"Mixed Phenotype Acute Leukemia, T/Megakaryocytic",0.7555555555555555,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.7555555555555555
MIXED SEROUS AND ENDOMETRIOID,Mixed Embryonal Carcinoma and Teratoma,0.5,Testicular Mixed Embryonal Carcinoma and Teratoma,0.4727272727272727,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,0.4727272727272727,Testicular Mixed Embryonal Carcinoma and Seminoma,0.4727272727272727,Breast Mixed Ductal and Lobular Carcinoma,0.4727272727272727
MLL-ALL,Acute Leukemia of Ambiguous Lineage,0.625,Refractory Acute Leukemia of Ambiguous Lineage,0.5555555555555556,Recurrent Acute Leukemia of Ambiguous Lineage,0.5555555555555556,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0.45454545454545453,Acute Leukemia of Ambiguous Lineage with BCL11B Rearrangement,0.45454545454545453
MMMT,Malignant Mixed Mesodermal (Mullerian) Tumor,0.3076923076923077,Advanced Malignant Mixed Mesodermal (Mullerian) Tumor,0.2857142857142857,Metastatic Malignant Mixed Mesodermal (Mullerian) Tumor,0.2857142857142857,Mixed Mesodermal (Mullerian) Tumor,0.23076923076923078,Malignant Parotid Gland Mixed Tumor,0.21428571428571427
MULTIPLE MYELOMA,Muscle Invasive Bladder Urothelial Carcinoma,0.38461538461538464,Recurrent Muscle Invasive Bladder Urothelial Carcinoma,0.35714285714285715,Localized Muscle Invasive Bladder Urothelial Carcinoma,0.35714285714285715,Multiple Myeloma,0.35384615384615387,Refractory Multiple Myeloma,0.34285714285714286
MULTIPLE_MYELOMA,Hematopoietic and Lymphoid Cell Neoplasm,0.2,Cutaneous Hematopoietic and Lymphoid Cell Neoplasm,0.1875,Childhood Hematopoietic and Lymphoid Cell Neoplasm,0.1875,Head and Neck Hematopoietic and Lymphoid Cell Neoplasm,0.17647058823529413,Central Nervous System Hematopoietic and Lymphoid Cell Neoplasm,0.16666666666666666
"MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE",Myelodysplastic/Myeloproliferative Neoplasm,0.575,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.5333333333333333,Recurrent Myelodysplastic/Myeloproliferative Neoplasm,0.5333333333333333,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.4727272727272727,Myelodysplastic/Myeloproliferative Neoplasm Post Cytotoxic Therapy,0.4727272727272727
MYELOMA,Plasma Cell Myeloma-Induced Bone Disease,0.4,Multiple Myeloma,0.325,Refractory Multiple Myeloma,0.3111111111111111,Recurrent Multiple Myeloma,0.3111111111111111,Non-Secretory Multiple Myeloma,0.3111111111111111
NESTED STROMAL EPITHELIAL TUMOR OF THE LIVER,Malignant Mixed Epithelial and Stromal Tumor of the Kidney,0.45454545454545453,Gastrointestinal Stromal Tumor of the Gastrointestinal Tract,0.4444444444444444,Extrarenal Rhabdoid Tumor of the Liver,0.4444444444444444,Calcifying Nested Stromal-Epithelial Tumor,0.4222222222222222,Rhabdoid Tumor of the Kidney,0.3333333333333333
NEUROTROPIC,Desmoplastic Neurotropic Melanoma,0.95,Desmoplastic Melanoma,0.5,Melanoma,0.25,Bladder Melanoma,0.2,Urethral Melanoma,0.2
NKC,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.6,B Lymphoblastic Leukemia/Lymphoma,0.2727272727272727,T Lymphoblastic Leukemia/Lymphoma,0.2727272727272727,Cutaneous B Lymphoblastic Leukemia/Lymphoma,0.25,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.25
NON-SEMINOMA,Testicular Non-Seminomatous Germ Cell Tumor,0.8666666666666667,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0.7714285714285714,Childhood Testicular Non-Seminomatous Germ Cell Tumor,0.7714285714285714,Stage IV Testicular Non-Seminomatous Germ Cell Tumor,0.7,Stage I Extragonadal Non-Seminomatous Germ Cell Tumor,0.7
NORMAL-LIKE,Invasive Breast Carcinoma,0.75,Invasive Breast Papillary Carcinoma,0.6,Invasive Breast Micropapillary Carcinoma,0.6,Invasive Female Breast Carcinoma,0.6,Invasive Male Breast Carcinoma,0.6
NO_FUSION,Recurrent Bone Ewing Sarcoma,0.42857142857142855,Ewing Sarcoma of Bone,0.42857142857142855,Localized Bone Ewing Sarcoma,0.42857142857142855,Metastatic Bone Ewing Sarcoma,0.42857142857142855,Bone Sarcoma,0.3333333333333333
NSCLC,Lung Non-Small Cell Carcinoma,0.375,Lung Non-Small Cell Cancer by AJCC v7 Stage,0.36363636363636365,Stage IV Lung Non-Small Cell Cancer AJCC v7,0.36363636363636365,Stage I Lung Non-Small Cell Cancer AJCC v7,0.36363636363636365,Stage II Lung Non-Small Cell Cancer AJCC v7,0.36363636363636365
OV,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.3666666666666667,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.35384615384615387,"Childhood Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.35384615384615387,Ovarian Carcinoma,0.3111111111111111,Metastatic Ovarian Carcinoma,0.30000000000000004
PAAD,Pancreatic Adenocarcinoma,0.3333333333333333,Refractory Pancreatic Adenocarcinoma,0.2857142857142857,Advanced Pancreatic Adenocarcinoma,0.2857142857142857,Metastatic Pancreatic Adenocarcinoma,0.2857142857142857,Unresectable Pancreatic Adenocarcinoma,0.2857142857142857
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND,Invasive Breast Papillary Carcinoma,0.6000000000000001,Invasive Breast Solid Papillary Carcinoma,0.5636363636363637,Breast Papillary Ductal Carcinoma In Situ,0.5333333333333333,Invasive Follicular Variant Thyroid Gland Papillary Carcinoma,0.5076923076923077,Breast Papillary Carcinoma,0.5
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND; BREAST,Invasive Breast Papillary Carcinoma,0.6000000000000001,Invasive Breast Solid Papillary Carcinoma,0.5636363636363637,Breast Papillary Ductal Carcinoma In Situ,0.5333333333333333,Invasive Follicular Variant Thyroid Gland Papillary Carcinoma,0.5076923076923077,Breast Papillary Carcinoma,0.5
"PAPILLARY, FOLLICULAR",Follicular Variant Thyroid Gland Papillary Carcinoma,0.5333333333333333,Thyroid Gland Papillary and Follicular Carcinoma,0.5333333333333333,Invasive Follicular Variant Thyroid Gland Papillary Carcinoma,0.5076923076923077,Invasive Encapsulated Follicular Variant Thyroid Gland Papillary Carcinoma,0.4857142857142857,Thyroid Gland Papillary Carcinoma,0.4727272727272727
PAST,Posterior Fossa Ependymoma,0.18181818181818182,Posterior Fossa Neoplasm,0.18181818181818182,Posterior Fossa Meningioma,0.18181818181818182,Childhood Posterior Fossa Ependymoma,0.16666666666666666,Adult Posterior Fossa Ependymoma,0.16666666666666666
PDA - MIXED DUCTAL ENDOCRINE CARCINOMA,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma,0.36363636363636365,Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma,0.3333333333333333,Pancreatic Ductal Adenocarcinoma,0.3,Refractory Pancreatic Ductal Adenocarcinoma,0.2727272727272727,Advanced Pancreatic Ductal Adenocarcinoma,0.2727272727272727
PDA - MUCINOUS NON-CYSTIC CARCINOMA,Pancreatic Carcinoma,0.2222222222222222,Pancreatic Adenocarcinoma,0.2222222222222222,Mucinous Adenocarcinoma,0.2222222222222222,Vaginal Mucinous Adenocarcinoma,0.2,Ovarian Mucinous Adenocarcinoma,0.2
PENILE SQUAMOUS CELL CARCINOMA,Penile Squamous Cell Carcinoma,0.7,Metastatic Penile Squamous Cell Carcinoma,0.6444444444444444,Unresectable Penile Squamous Cell Carcinoma,0.6444444444444444,Penile Clear Cell Squamous Cell Carcinoma,0.6444444444444444,Penile Basaloid Squamous Cell Carcinoma,0.6444444444444444
PERITONEAL MESOTHELIOMA,Peritoneal Malignant Mesothelioma,0.7,Peritoneal Sarcomatoid Mesothelioma,0.7,Peritoneal Biphasic Mesothelioma,0.7,Peritoneal Epithelioid Mesothelioma,0.7,Peritoneal Multicystic Mesothelioma,0.7
PERIVASCULAR EPITHELIOID CELL TUMOR,Giant Cell Tumor of Soft Tissue,0.36363636363636365,Clear Cell Sarcoma of Soft Tissue,0.36363636363636365,"Testicular Yolk Sac Tumor, Endodermal Sinus/Perivascular Pattern",0.33333333333333337,Childhood Clear Cell Sarcoma of Soft Tissue,0.3333333333333333,Recurrent Clear Cell Sarcoma of Soft Tissue,0.3333333333333333
PFA,"Posterior Fossa Ependymoma, Group A (PFA)",0.4857142857142857,Glioma,0.3333333333333333,Ependymoma,0.3333333333333333,Recurrent Glioma,0.25,Recurrent Ependymoma,0.25
PH-LIKEALL,B Lymphoblastic Leukemia/Lymphoma,0.2222222222222222,Adult T-Cell Leukemia/Lymphoma,0.2222222222222222,T Lymphoblastic Leukemia/Lymphoma,0.2222222222222222,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.2,Cutaneous B Lymphoblastic Leukemia/Lymphoma,0.2
PITUITARY ADENOMA,Pituitary Gland Basophil Adenoma,0.6285714285714286,Pituitary Gland Chromophobe Adenoma,0.6285714285714286,Pituitary Gland Acidophil Adenoma,0.6285714285714286,Pituitary Gland Mixed Acidophil-Basophil Adenoma,0.575,Pituitary Neuroendocrine Tumor,0.4857142857142857
PLASMA CELL MYELOMA,Plasma Cell Leukemia,0.45,Plasma Cell Neoplasm,0.45,Refractory Plasma Cell Neoplasm,0.4222222222222222,Recurrent Plasma Cell Leukemia,0.4222222222222222,Recurrent Plasma Cell Neoplasm,0.4222222222222222
PLASMA_CELL_MYELOMA,Hematopoietic and Lymphoid Cell Neoplasm,0.2,Cutaneous Hematopoietic and Lymphoid Cell Neoplasm,0.1875,Childhood Hematopoietic and Lymphoid Cell Neoplasm,0.1875,Head and Neck Hematopoietic and Lymphoid Cell Neoplasm,0.17647058823529413,Central Nervous System Hematopoietic and Lymphoid Cell Neoplasm,0.16666666666666666
PLEURAL MESOTHELIOMA,Pleural Epithelioid Mesothelioma,0.7,Unresectable Pleural Epithelioid Mesothelioma,0.6285714285714286,Pleural Epithelioid Hemangioendothelioma,0.4857142857142857,Pleural Malignant Mesothelioma,0.4857142857142857,Pleural Sarcomatoid Mesothelioma,0.4857142857142857
PLMESO,Pleural Malignant Mesothelioma,0.4,Pleural Epithelioid Mesothelioma,0.4,Pleural Sarcomatoid Mesothelioma,0.4,Pleural Desmoplastic Mesothelioma,0.4,Pleural Biphasic Mesothelioma,0.4
PNET,Peripheral Nervous System Neoplasm,0.375,Central Nervous System Neuroblastoma,0.375,Childhood Peripheral Nervous System Neoplasm,0.3333333333333333,Childhood Central Nervous System Neuroblastoma,0.3333333333333333,Malignant Peripheral Nervous System Neoplasm,0.3333333333333333
POORLY DIFFERENTIATED OR PLEOMORPHIC OR EPITHELIOID LEIOMYOSARCOMA,Poorly Differentiated Synovial Sarcoma,0.4,Poorly Differentiated Neuroblastoma,0.33333333333333337,Poorly Differentiated Angiosarcoma,0.33333333333333337,Poorly Differentiated Chordoma,0.33333333333333337,Poorly Differentiated Fibrosarcoma,0.33333333333333337
PRAD,Prostate Adenocarcinoma,0.7,Advanced Prostate Adenocarcinoma,0.6000000000000001,Metastatic Prostate Adenocarcinoma,0.6000000000000001,Refractory Prostate Adenocarcinoma,0.6000000000000001,Localized Prostate Adenocarcinoma,0.6000000000000001
PRE-T,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.4444444444444444,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.4444444444444444,Breast Ductal Carcinoma,0.42857142857142855,Invasive Breast Carcinoma,0.42857142857142855,Breast Paget Disease with Invasive Ductal Carcinoma,0.4
PRIMARY CNS MELANOMA,Melanoma of Unknown Primary,0.4857142857142857,Primary Amyloidosis,0.3666666666666667,Primary Myelofibrosis,0.3666666666666667,Primary Neoplasm,0.3666666666666667,Primary Peritoneal Carcinosarcoma,0.34285714285714286
PRO MYELOCYTIC LEUKEMIA,Acute Myeloid Leukemia Arising from Previous Myeloproliferative Neoplasm,0.4307692307692308,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm,0.41428571428571426,Mature Plasmacytoid Dendritic Cell Proliferation Associated with Myeloid Neoplasm,0.33333333333333337,Prostate Neoplasm,0.3111111111111111,Prolymphocytic Leukemia,0.3111111111111111
RAEB,Myelodysplastic Syndrome with Excess Blasts,0.4444444444444444,Childhood Myelodysplastic Syndrome with Excess Blasts,0.4,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,0.36363636363636365,Myelodysplastic Syndrome with Low Blasts,0.3,Childhood Myelodysplastic Syndrome with Low Blasts,0.2727272727272727
RARS,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",0.4375,Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis,0.3333333333333333,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.3333333333333333,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.3125,Myelodysplastic Syndrome with Ring Sideroblasts,0.3076923076923077
RARS-T,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",0.4375,Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis,0.3333333333333333,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.3333333333333333,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.3125,Myelodysplastic Syndrome with Ring Sideroblasts,0.3076923076923077
RCMD,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.3333333333333333,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.3333333333333333,Acute Myeloid Leukemia with Multilineage Dysplasia,0.2727272727272727,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,0.25,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.25
READ,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.5,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.5,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.45454545454545453,T Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities,0.45454545454545453,B Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities,0.45454545454545453
READ_GS,Rectal Adenocarcinoma,0.2857142857142857,Colorectal Adenocarcinoma,0.2857142857142857,Metastatic Rectal Adenocarcinoma,0.25,Advanced Rectal Adenocarcinoma,0.25,Refractory Rectal Adenocarcinoma,0.25
REFRACTORY ANEMIA WITH EXCESS BLASTS-2,Refractory Anemia with Excess Blasts in Transformation,0.5076923076923077,Refractory Anemia,0.4,Refractory Myelodysplastic Syndrome,0.38181818181818183,Refractory Primary Bone Lymphoma,0.3666666666666667,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.3666666666666667
REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,Refractory Myelodysplastic Syndrome,0.4,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.38181818181818183,Refractory Cytopenia of Childhood,0.38181818181818183,Refractory Anemia with Excess Blasts in Transformation,0.34285714285714286,Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation,0.325
RENAL SPINDLE CELL CARCINOMA,Renal Cell Carcinoma,0.8,Advanced Renal Cell Carcinoma,0.7,Metastatic Renal Cell Carcinoma,0.7,Refractory Renal Cell Carcinoma,0.7,Recurrent Renal Cell Carcinoma,0.7
ROSAI-DORFMAN DISEASE,Rosai-Dorfman-Destombes Disease,0.3666666666666667,Cutaneous Rosai-Dorfman-Destombes Disease,0.34285714285714286,Bone Rosai-Dorfman-Destombes Disease,0.34285714285714286,Thyroid Gland Rosai-Dorfman-Destombes Disease,0.325,Head and Neck Rosai-Dorfman-Destombes Disease,0.3111111111111111
"ROUND CELL SARCOMA, OTHER",Undifferentiated Round Cell Sarcoma,0.6285714285714286,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.5333333333333333,Childhood Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.5,Clear Cell Sarcoma of Soft Tissue,0.5,Soft Tissue Sarcoma,0.5
RT,Adrenal Cortical Carcinoma,0.4222222222222222,Childhood Adrenal Cortical Carcinoma,0.4,Recurrent Adrenal Cortical Carcinoma,0.4,Refractory Adrenal Cortical Carcinoma,0.4,Unresectable Adrenal Cortical Carcinoma,0.4
SARC LMS,Uterine Corpus Sarcoma,0.4222222222222222,Uterine Corpus Leiomyosarcoma,0.4222222222222222,Metastatic Uterine Corpus Sarcoma,0.4,Metastatic Uterine Corpus Leiomyosarcoma,0.4,Recurrent Uterine Corpus Sarcoma,0.4
SARC LS,Soft Tissue Sarcoma,0.4727272727272727,Laryngeal Soft Tissue Sarcoma,0.45,Childhood Soft Tissue Sarcoma,0.45,Recurrent Soft Tissue Sarcoma,0.45,Refractory Soft Tissue Sarcoma,0.45
SARCOMA LEIOMYO,Uterine Corpus Sarcoma,0.4857142857142857,Uterine Corpus Leiomyosarcoma,0.4857142857142857,Metastatic Uterine Corpus Sarcoma,0.45,Metastatic Uterine Corpus Leiomyosarcoma,0.45,Recurrent Uterine Corpus Sarcoma,0.45
SARC_DDLPS,Dedifferentiated Liposarcoma,0.3333333333333333,Unresectable Dedifferentiated Liposarcoma,0.2857142857142857,Refractory Dedifferentiated Liposarcoma,0.2857142857142857,Resectable Dedifferentiated Liposarcoma,0.2857142857142857,Recurrent Dedifferentiated Liposarcoma,0.2857142857142857
SARC_LMS,Leiomyosarcoma,0.2,Sarcoma,0.2,Cervical Leiomyosarcoma,0.16666666666666666,Vaginal Sarcoma,0.16666666666666666,Vaginal Leiomyosarcoma,0.16666666666666666
SARC_OTHER,Biphasic Synovial Sarcoma,0.42857142857142855,Lung Biphasic Synovial Sarcoma,0.375,Cardiac Biphasic Synovial Sarcoma,0.375,Pleural Biphasic Synovial Sarcoma,0.375,Synovial Sarcoma,0.2857142857142857
SBS,Small Intestinal Cancer by AJCC v7 Stage,0.18181818181818182,Stage III Small Intestinal Cancer AJCC v7,0.18181818181818182,Stage IIIA Small Intestinal Cancer AJCC v7,0.18181818181818182,Stage IIIB Small Intestinal Cancer AJCC v7,0.18181818181818182,Stage IV Small Intestinal Cancer AJCC v7,0.18181818181818182
SCCOHT,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.5,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.46153846153846156,"Childhood Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.46153846153846156,Ovarian Small Cell Carcinoma,0.3333333333333333,"Ovarian Small Cell Carcinoma, Pulmonary-Type",0.3076923076923077
SCHMINKE TUMOR/LYMPHOEPITHELIAL CARCINOMA,Laryngeal Lymphoepithelial Carcinoma,0.4,Sinonasal Lymphoepithelial Carcinoma,0.4,Lung Lymphoepithelial Carcinoma,0.4,Skin Lymphoepithelial Carcinoma,0.4,Thymic Lymphoepithelial Carcinoma,0.4
"SEROUS BORDERLINE OVARIAN TUMOR, MICROPAPILLARY",Borderline Ovarian Serous Tumor,0.7,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,0.6000000000000001,Borderline Ovarian Serous Papillary Cystic Tumor,0.6000000000000001,Borderline Ovarian Serous Surface Papillary Tumor,0.6000000000000001,Ovarian Serous Tumor,0.575
SEROUS_CARCINOMA,Malignant Mixed Mesodermal (Mullerian) Tumor,0.36363636363636365,Advanced Malignant Mixed Mesodermal (Mullerian) Tumor,0.3333333333333333,Metastatic Malignant Mixed Mesodermal (Mullerian) Tumor,0.3333333333333333,Malignant Ovarian Brenner Tumor,0.2727272727272727,Malignant Ovarian Epithelial Tumor,0.2727272727272727
SKCM,Cutaneous Melanoma,0.5,Melanoma in Intermittently Sun-Exposed Skin,0.4857142857142857,Melanoma in Chronically Sun-Exposed Skin,0.4857142857142857,Metastatic Melanoma in the Skin,0.4857142857142857,Penile Cutaneous Melanoma,0.4
SMALL CELL CARCINOMA OF UNKNOWN PRIMARY,Liver Small Cell Neuroendocrine Carcinoma,0.6000000000000001,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,0.5333333333333333,Ovarian Small Cell Carcinoma,0.5,Small Cell Neuroendocrine Carcinoma,0.5,Lung Small Cell Carcinoma,0.5
SMOLDERING MYELOMA,Smoldering Multiple Myeloma,0.4222222222222222,Smoldering Waldenstrom Macroglobulinemia,0.30000000000000004,Smoldering Systemic Mastocytosis,0.30000000000000004,Smoldering Adult T-Cell Leukemia/Lymphoma,0.2833333333333333,Smoldering Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.26666666666666666
SOFT TISSUE MYOEPITHELIAL CARCINOMA,Soft Tissue Sarcoma,0.575,Liver Soft Tissue Neoplasm,0.5333333333333333,Laryngeal Soft Tissue Sarcoma,0.5333333333333333,Childhood Soft Tissue Sarcoma,0.5333333333333333,Recurrent Soft Tissue Sarcoma,0.5333333333333333
SPECIFIC_DX_AT_ACQUISITION_MDSMPN,Acute Myeloid Leukemia,0.6,Refractory Acute Myeloid Leukemia,0.5,Recurrent Acute Myeloid Leukemia,0.5,Secondary Acute Myeloid Leukemia,0.5,Benzene-Related Acute Myeloid Leukemia,0.5
ST-RELPOS,Glioma,0.3333333333333333,Ependymoma,0.3333333333333333,Recurrent Glioma,0.25,Recurrent Ependymoma,0.25,Childhood Ependymoma,0.25
ST-YAP,Glioma,0.3333333333333333,Ependymoma,0.3333333333333333,Recurrent Glioma,0.25,Recurrent Ependymoma,0.25,Childhood Ependymoma,0.25
STAD,Ovarian Mucinous Cystadenocarcinoma,0.5,Ovarian Cystadenocarcinoma,0.4,Mucinous Cystadenocarcinoma,0.4,Ovarian Mucinous Cystadenoma,0.38181818181818183,Ovarian Mucinous Cystadenofibroma,0.38181818181818183
STAD_GS,Adenocarcinoma,0.14285714285714285,Vaginal Adenocarcinoma,0.125,Mesonephric Adenocarcinoma,0.125,Vulvar Adenocarcinoma,0.125,Ovarian Adenocarcinoma,0.125
SUPERFICIAL SPREADING,"Low-CSD Melanoma, Superficial Spreading Melanoma Subtype",0.575,Superficial Spreading Adenocarcinoma,0.4857142857142857,Superficial Angiomyxoma,0.34285714285714286,Superficial Fibromatosis,0.34285714285714286,Vaginal Superficial Myofibroblastoma,0.325
SUPERFICIAL SPREADING MELANOMA,"Low-CSD Melanoma, Superficial Spreading Melanoma Subtype",0.7,Superficial Spreading Adenocarcinoma,0.6000000000000001,Superficial Angiomyxoma,0.4,Superficial Fibromatosis,0.4,Vaginal Superficial Myofibroblastoma,0.3666666666666667
SWEAT GLAND ADENOCARCINOMA,Vulvar Adenocarcinoma of Sweat Gland Origin,0.4727272727272727,Sweat Gland Adenoma,0.4222222222222222,Sweat Gland Carcinoma,0.4222222222222222,Sweat Gland Neoplasm,0.4222222222222222,Benign Sweat Gland Neoplasm,0.4
S_T_MDS,Neoplasm by Site,0.0,Genitourinary System Neoplasm,0.0,Benign Genitourinary System Neoplasm,0.0,Childhood Benign Genitourinary System Neoplasm,0.0,Childhood Testicular Mature Teratoma,0.0
"T-CELL, NON-HODGKINS, CUTANEOUS",Cutaneous Mature T-Cell and NK-Cell Neoplasm,0.45,Mature T-Cell and NK-Cell Neoplasm,0.3875,Refractory Mature T-Cell and NK-Cell Neoplasm,0.3764705882352941,Recurrent Mature T-Cell and NK-Cell Neoplasm,0.3764705882352941,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0.3764705882352941
"T-CELL, NON-HODGKINS, CUTANEOUS, SEZARY SYNDROME",Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6444444444444444,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6000000000000001,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6000000000000001,Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6000000000000001,Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6000000000000001
T-CELL_ALL,Endometrial Mucosa-Associated Lymphoid Tissue Lymphoma,0.25,Bladder Mucosa-Associated Lymphoid Tissue Lymphoma,0.25,Breast Mucosa-Associated Lymphoid Tissue Lymphoma,0.25,Colon Mucosa-Associated Lymphoid Tissue Lymphoma,0.25,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0.25
TALL,Acute Adult T-Cell Leukemia/Lymphoma,0.42857142857142855,Lymphoid Leukemia,0.4,Acute Leukemia,0.4,Refractory Acute Leukemia,0.3333333333333333,Recurrent Acute Leukemia,0.3333333333333333
TC:SCC,Ovarian Epithelial Tumor,0.2857142857142857,Thymic Neuroendocrine Tumor,0.2857142857142857,Thymic Epithelial Neoplasm,0.2857142857142857,Benign Ovarian Epithelial Tumor,0.25,Malignant Ovarian Epithelial Tumor,0.25
TGCT SEM,Testicular Germ Cell Tumor,0.5,Malignant Testicular Germ Cell Tumor,0.4444444444444444,Testicular Mixed Germ Cell Tumor,0.4444444444444444,Childhood Testicular Germ Cell Tumor,0.4444444444444444,Familial Testicular Germ Cell Tumor,0.4444444444444444
THCA,Muscle Invasive Bladder Urothelial Carcinoma,0.4166666666666667,Recurrent Muscle Invasive Bladder Urothelial Carcinoma,0.38461538461538464,Localized Muscle Invasive Bladder Urothelial Carcinoma,0.38461538461538464,Invasive Bladder Urothelial Carcinoma,0.3333333333333333,Muscle Invasive Bladder Carcinoma,0.3333333333333333
THERAPY-RELATED MYELODYSPLASTIC SYNDROME,Therapy-Related Leukemia,0.6000000000000001,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.42857142857142855,Myelodysplastic Syndrome,0.4,Chemotherapy-Related Leukemia,0.3666666666666667,Therapy-Related Neoplasm,0.3666666666666667
THERAPY-RELATED MYELOID NEOPLASMS,Therapy-Related Leukemia,0.6000000000000001,Myeloid Leukemia,0.4,Chemotherapy-Related Leukemia,0.3666666666666667,Therapy-Related Neoplasm,0.3666666666666667,Therapy-Related Malignant Neoplasm,0.34285714285714286
THPA,Thyroid Gland Papillary Carcinoma,0.5,Childhood Thyroid Gland Papillary Carcinoma,0.42857142857142855,Recurrent Thyroid Gland Papillary Carcinoma,0.42857142857142855,Refractory Thyroid Gland Papillary Carcinoma,0.42857142857142855,Unresectable Thyroid Gland Papillary Carcinoma,0.42857142857142855
THPD,Poorly Differentiated Thyroid Gland Carcinoma,0.375,Recurrent Poorly Differentiated Thyroid Gland Carcinoma,0.3333333333333333,Metastatic Poorly Differentiated Thyroid Gland Carcinoma,0.3333333333333333,Unresectable Poorly Differentiated Thyroid Gland Carcinoma,0.3333333333333333,Poorly Differentiated Neuroblastoma,0.2857142857142857
THYMOMA; TYPE C,Thymoma Type B3,0.4857142857142857,Thymoma Type A,0.4857142857142857,Thymoma Type AB,0.4857142857142857,Thymoma Type B,0.4857142857142857,Thymoma Type B1,0.4857142857142857
TRANSLOCATION-ASSOCIATED RENAL CELL CARCINOMA,Renal Cell Carcinoma,0.5,Advanced Renal Cell Carcinoma,0.42857142857142855,Metastatic Renal Cell Carcinoma,0.42857142857142855,Refractory Renal Cell Carcinoma,0.42857142857142855,Recurrent Renal Cell Carcinoma,0.42857142857142855
TYPE A,"Mixed Phenotype Acute Leukemia, T/Myeloid",0.8,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",0.7454545454545454,"Mixed Phenotype Acute Leukemia, B/T",0.6545454545454545,"Mixed Phenotype Acute Leukemia, T/Megakaryocytic",0.6545454545454545,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.6545454545454545
TYPE C,Thymoma Type B3,0.4857142857142857,Thymoma Type A,0.4857142857142857,Thymoma Type AB,0.4857142857142857,Thymoma Type B,0.4857142857142857,Thymoma Type B1,0.4857142857142857
T_CELL_ALCL,Anaplastic Large Cell Lymphoma,0.25,Lung Anaplastic Large Cell Lymphoma,0.23529411764705882,Refractory Anaplastic Large Cell Lymphoma,0.23529411764705882,Recurrent Anaplastic Large Cell Lymphoma,0.23529411764705882,Localized Anaplastic Large Cell Lymphoma,0.23529411764705882
UCEC ENDO,Endometrial Carcinoma,0.2,Lung Carcinoma,0.2,Metastatic Endometrial Carcinoma,0.18181818181818182,Advanced Endometrial Carcinoma,0.18181818181818182,Endometrial Adenosquamous Carcinoma,0.18181818181818182
UCS,Uterine Carcinosarcoma,0.45,Uterine Corpus Carcinosarcoma,0.4222222222222222,Advanced Uterine Corpus Carcinosarcoma,0.4,Recurrent Uterine Corpus Carcinosarcoma,0.4,Refractory Uterine Corpus Carcinosarcoma,0.4
UM,Uveal Intermediate Cell Type Melanoma,0.4727272727272727,Uveal Spindle Cell Type A Melanoma,0.45,Uveal Spindle Cell Type B Melanoma,0.45,Uveal Melanoma,0.4222222222222222,Metastatic Uveal Melanoma,0.4
UNCLASSIFIED RENAL CELL CARCINOMA,Renal Cell Carcinoma,0.6,Advanced Renal Cell Carcinoma,0.5,Metastatic Renal Cell Carcinoma,0.5,Refractory Renal Cell Carcinoma,0.5,Recurrent Renal Cell Carcinoma,0.5
UNKNOWN TUMOR,Adenocarcinoma of Unknown Primary,0.3111111111111111,Carcinoma of Unknown Primary,0.3111111111111111,Melanoma of Unknown Primary,0.3111111111111111,Neuroendocrine Carcinoma of Unknown Primary,0.30000000000000004,Resectable Carcinoma of Unknown Primary,0.30000000000000004
URACHAL ADENOCARCINOMA,Urachal Adenocarcinoma,0.45,Urachal Carcinoma,0.3111111111111111,Urachal Urothelial Carcinoma,0.30000000000000004,Metastatic Urachal Urothelial Carcinoma,0.2909090909090909,Urachal Squamous Cell Carcinoma,0.2909090909090909
URACHAL CARCINOMA,Urachal Carcinoma,0.6000000000000001,Urachal Urothelial Carcinoma,0.5333333333333333,Metastatic Urachal Urothelial Carcinoma,0.4857142857142857,Urachal Squamous Cell Carcinoma,0.4857142857142857,Bladder Carcinoma,0.4
UTERINE PERIVASCULAR EPITHELIOID CELL TUMOR,Uterine Corpus Germ Cell Tumor,0.5,Uterine Corpus Sarcoma,0.4222222222222222,Uterine Corpus Adenomatoid Tumor,0.4,Uterine Corpus Epithelioid Leiomyoma,0.4,Metastatic Uterine Corpus Sarcoma,0.4
UVM,Uveal Melanoma,1.2,Metastatic Uveal Melanoma,0.8666666666666667,Advanced Uveal Melanoma,0.8666666666666667,Unresectable Uveal Melanoma,0.8666666666666667,Refractory Uveal Melanoma,0.8666666666666667
